Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report

Table 1

Baseline characteristics.

Baseline characteristics of the enrolled patients; (mean ± SD)
Variable	PC-Lycosome	PC
Number of patients	14	15
Males	8	9
Females	6	6
Age	49.1 ± 4.8	51.2 ± 5.7
Light/moderate smokers	4	5
Body mass index	29.5 ± 3.3	28.4 ± 3.8
AST in U/L	39.14 ± 3.77	38.71 ± 3.19
ALT in U/L	60.50 ± 5.54	60.78 ± 5.05
Fasting glucose in mmol/L	5.5 ± 0.49	6.2 ± 0.61
Total cholesterol in mg/Dl	272.0 ± 15.5	262.3 ± 14.2
Triglycerides in mg/Dl	128 ± 12.6	129 ± 12.9
LDL in mg/Dl	220 ± 19.2	207 ± 17.2
HDL in mg/Dl	43.3 ± 3.9	41.4 ± 3.3
Pulse rate per min	71.8 ± 4.2	72.1 ± 5.3
Blood pressure in mm Hg
Systolic	121.5 ± 7.9	120.8 ± 6.4
Diastolic	75.7 ± 5.2	75.1 ± 6.0
Liver size in cm
Mid-clavicular line	16.10 ± 0.58	16.2 ± 0.60
Mid-sternal line	7.19 ± 0.43	7.12 ± 0.34

The patients were screened, enrolled, and randomized into two major groups for the study as described in Materials and Methods. Baseline characteristics from the time point “0” of the study were expressed as mean values with standard deviations and are shown above.